Department of Cranio-Maxillofacial Surgery, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
Clin Oral Investig. 2021 Sep;25(9):5541-5550. doi: 10.1007/s00784-021-03864-1. Epub 2021 Mar 8.
The aim of this study was to determine the influence of perioperative fluid management and administration of vasopressors on early surgical revision and flap-related complications in free tissue transfer.
Intraoperative amount of fluid and of vasopressors, relevant perioperative parameters, and comorbidities were recorded in 131 patients undergoing head and neck microvascular reconstruction and compared with early surgical complications, defined as interventions requiring surgery after a flap-related complication, and/or other surgical problems in the operating room within 30 days after initial surgery. The relationship between perioperative variables for each revision category was determined using an optimized multiple logistic regression.
The administration of diuretics (p=0.001) as a treatment for perioperative fluid overload and the type of flap (p=0.019) was associated with a higher risk of early surgical revisions. Perioperative fluid overload (p=0.039) is significantly related to flap-related complications. We found no effect of intraoperative administration of vasopressors on early surgical revisions (p=0.8) or on flap-related complications (norepinephrine p=0.6, dobutamine p=0.5).
Perioperative fluid overload is associated with higher risks of early surgical revision and flap-related complications. In contrast, the administration of vasopressors seemed to have no effect on either surgical revision rate or flap-related complications.
In patients receiving microvascular reconstructions, a balanced fluid administration perioperatively and a targeted use of vasopressors should be the necessary strategy to reduce the complication rates in head and neck surgery.
本研究旨在确定围手术期液体管理和血管加压素的使用对游离组织移植中早期手术翻修和皮瓣相关并发症的影响。
记录了 131 例头颈部微血管重建患者的术中液体量和血管加压素用量、相关围手术期参数和合并症,并将其与早期手术并发症进行比较,早期手术并发症定义为在初始手术后 30 天内因皮瓣相关并发症而需要手术干预和/或手术室中其他手术问题。使用优化的多因素逻辑回归确定每个修订类别中围手术期变量之间的关系。
利尿剂的使用(p=0.001)作为治疗围手术期液体超负荷的方法以及皮瓣类型(p=0.019)与早期手术翻修的风险增加相关。围手术期液体超负荷(p=0.039)与皮瓣相关并发症显著相关。我们发现术中血管加压素的使用对早期手术翻修(p=0.8)或皮瓣相关并发症(去甲肾上腺素 p=0.6,多巴酚丁胺 p=0.5)均无影响。
围手术期液体超负荷与早期手术翻修和皮瓣相关并发症的风险增加相关。相反,血管加压素的使用似乎对手术翻修率或皮瓣相关并发症没有影响。
在接受微血管重建的患者中,围手术期平衡液体管理和靶向使用血管加压素应是降低头颈部手术并发症发生率的必要策略。